Cytomegalovirus infection and Guillain-Barré syndrome: A first case-control study in children in Iran
Iranian Journal of Child Neurology,
Vol. 15 No. 4 (2021),
1 October 2021
https://doi.org/10.22037/ijcn.v15i4.31285
Abstract
Objective: Guillain-Barré syndrome (GBS) is an immune-mediated disease of the peripheral nervous system which affects all age groups through the world. Although the pathogenesis and optimal treatment of GBS are still not completely established, one of the most common infectious diseases to trigger the syndrome is cytomegalovirus (CMV) infection. GBS following CMV infections is rarely reported in childhood and there is no data on GBS with antecedent CMV infection in children in Iran. The aim of this study was to evaluate the association of CMV infection and GBS in children in Iran.
Materials & Methods: Case-control study design was used in 30 cases of Guillain-Barre syndrome, and 30 matched controls. All serum samples were tested for the presence of anti-CMV IgM and IgG antibodies using a commercially available ELISA (EUROIMMUN Medizinische, Germany).CMV viral DNA in the specimen was detected using polymerase chain reaction (PCR), (Cytomegalovirus PCR Detection Kit, CinnaGen company, Iran).
Results: Anti–CMV immunoglobulin (Ig) G antibodies were detected in GBS patients and healthy controls in 97% and 93% of children, respectively. Anti-CMV IgM antibodies were demonstrated in 33% (n=10) of the healthy controls and 33% (n=10) of the children with GBS. The borderline level of anti-CMV IgM antibodies was found in 23% healthy controls (n=7) and 13% (n=4) in the children with GBS (p=0.57), respectively. None of the specimens from the both controls the cases with GBS was positive for CMV DNA by PCR.
Conclusion: These data demonstrated the presence of anti-CMV antibodies in a majority of both patients with GBS and controls and no relation between CMV infection and GBS was observed. However, further studies with larges sample sizes are highly recommended.
- Guillain-Barré syndrome, cytomegalovirus, children
How to Cite
References
2. Leung J, Sejvar JJ, Soares J, Lanzieri TM. Guillain-Barré syndrome and antecedent cytomegalovirus infection, USA 2009–2015. Neurological Sciences. 2019:1-7.
3. Silva CT, Silva S, Silva MJ, Almeida AF, Fonseca J, Melo C, et al. Guillain-Barré Syndrome in a Teenage Girl: A Severe Case With Anti-GM2 Antibodies Associated With Acute CMV Infection and Literature Review. Clinical Pediatrics. 2020;59(3):300-4.
4. Yuki N, Hartung H-P. Guillain–Barré syndrome. New England Journal of Medicine. 2012;366(24):2294-304.
5. Rudant J, Dupont A, Mikaeloff Y, Bolgert F, Coste J, Weill A. Surgery and risk of Guillain-Barré syndrome: a French nationwide epidemiologic study. Neurology. 2018;91(13):e1220-e7.
6. Agrawal S, Peake D, Whitehouse W. Management of children with Guillain-Barré syndrome. Archives of Disease in Childhood-Education and Practice. 2007;92(6):161-8.
7. Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix J-C, Raphaël J-C, Durand M-C, et al. Guillain–Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clinical infectious diseases. 2011;52(7):837-44.
8. Kuijf ML, Ang CW, van Doorn PA, Niesters HG, Jacobs BC. Presence or absence of cytomegalovirus in cerebrospinal fluid from patients with Guillain-Barre syndrome? The Journal of infectious diseases. 2006;193(10):1471-2.
9. Steininger C, Popow-Kraupp T, Seiser A, Gueler N, Stanek G, Puchhammer E. Presence of cytomegalovirus in cerebrospinal fluid of patients with Guillain-Barre syndrome. The Journal of infectious diseases. 2004;189(6):984-9.
10. Kalra V, Chaudhry R, Dua T, Dhawan B, Sahu JK, Mridula B. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study. Journal of child neurology. 2009;24(6):664-8.
11. Poropatich KO, Walker CLF, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. Journal of health, population, and nutrition. 2010;28(6):545.
12. Meyer Sauteur PM, Huizinga R, Tio‐Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, et al. Mycoplasma pneumoniae triggering the Guillain‐Barré syndrome: a case‐control study. Annals of neurology. 2016;80(4):566-80.
13. Counotte MJ, Meili KW, Taghavi K, Calvet G, Sejvar J, Low N. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: A living systematic review. F1000Research. 2019;8.
14. Arnaud S, Budowski C, Tin SNW, Degos B. Post SARS-CoV-2 Guillain-Barré syndrome. Clinical Neurophysiology. 2020.
15. Hughes R, Hadden R, Gregson N, Smith K. Pathogenesis of Guillain–Barré syndrome. Journal of neuroimmunology. 1999;100(1-2):74-97.
16. Spagnoli C, Iodice A, Salerno GG, Frattini D, Bertani G, Pisani F, et al. CMV-associated axonal sensory-motor Guillain–Barré syndrome in a child: Case report and review of the literature. european journal of paediatric neurology. 2016;20(1):168-75.
17. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain‐Barré syndrome. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1990;27(S1):S21-S4.
18. Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF. Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation. Neurology. 2000;54(12):2311-5.
19. Chand P, Jan F, Kaleem S, Yousafzai MT, Ibrahim S. Description of Guillain-Barre syndrome on the basis of clinical features using Hughes scoring system among children in Karachi, Pakistan. Asia Pacific Journal of Clinical Trials: Nervous System Diseases. 2017;2(2):45.
20. Jacobs B, Rothbarth P, Van der Meché F, Herbrink P, Schmitz P, De Klerk M, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51(4):1110-5.
21. Lunn M, Hughes R. The relationship between cytomegalovirus infection and Guillain–Barré syndrome. Oxford University Press; 2011.
- Abstract Viewed: 847 times